Clinical Trials
2 trialsNCT07605962 2026-06-03
Phase 1/2 Study of UI-102 in Selected Advanced Cancers
United Immunity, co., Ltd.
Phase 1/2 Recruiting
NCT06656390 2026-05-22
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1/2 Recruiting